Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases

Overview of attention for article published in Frontiers in Pharmacology, March 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 80 Dimensions

Readers on

mendeley: 111 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 9,625 followers.

Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases https://t.co/i62fIFvGC6

16 Jul 2020

Reply Repost Favourite

Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases (2020) https://t.co/0kpljNnwfz

01 Apr 2020

Reply Repost Favourite

I can't get any distribution for my Tweets about ibudilast but again I would be REALLY interested in knowing if the PDE4 inhibitors like ibudilast were tried in ARDS in Japan et al. Important-> https://t.co/PvpMKrqrJt nebulized #ibudilast for #COVID19

01 Apr 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.